Advertisement
Screener

Johnson & Johnson (JNJ) EBITDA

Johnson & Johnson (JNJ) EBITDA

  • 2026-03-29: Basis Reported; EBITDA (m); Operating income (m); Depreciation and amortization $2.00B.
  • 2025-03-30: Basis Reported; EBITDA (m); Operating income (m); Depreciation and amortization $1.77B.
  • 2024-03-31: Basis Reported; EBITDA (m); Operating income (m); Depreciation and amortization $1.81B.
  • 2023-04-02: Basis Reported; EBITDA (m); Operating income (m); Depreciation and amortization $1.88B.

Complete source-backed ebitda history.

Available history
2010-01-03 to 2015-03-29
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-03-29Reported(m)(m)$2.00B$24.06B(m)$1.05B$2.51B$8.11B(m)$6.03B$755.00M
2025-03-30Reported(m)(m)$1.77B$21.89B(m)$795.00M$4.17B$7.36B(m)$5.11B$2.63B
2024-03-31Reported(m)(m)$1.81B$21.38B(m)$807.00M$3.66B$6.51B(m)$5.26B$459.00M
2023-04-02Reported(m)(m)$1.88B$20.89B(m)$863.00M$3.26B$6.69B(m)$4.91B-$796.00M
2022-04-03Reported(m)(m)$1.77B$19.84B(m)$607.00M$3.98B$7.60B(m)$5.94B$713.00M
2021-04-04Reported(m)(m)$1.89B$22.32B(m)$677.00M$4.07B$7.06B(m)$5.43B$1.23B
2020-03-29Reported(m)(m)$1.75B$20.69B(m)$625.00M$3.36B$7.06B(m)$5.20B$713.00M
2019-03-31Reported(m)(m)$1.76B$20.02B(m)$656.00M$3.54B$6.62B(m)$5.22B$673.00M
2018-04-01Reported(m)(m)$1.75B$20.01B(m)$658.00M$3.61B$6.61B(m)$5.26B$1.11B
2017-04-02Reported(m)(m)$912.00M$17.77B(m)$560.00M$2.91B(m)(m)$4.76B$1.15B
2016-04-03Reported(m)(m)$891.00M(m)(m)$639.00M$2.19B(m)(m)$4.69B$837.00M
2015-03-29Reported$6.72B(m)(m)(m)(m)$543.00M$2.87B(m)(m)$4.85B$1.25B
2014-12-28Reported$4B(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2014-09-28Reported$7.99B*$7.05B$939.00M*(m)(m)$751.00M*$4.65B*(m)(m)$5.47B$2.06B
2014-06-29Reported$6.83B*$5.88B$952.00M*(m)(m)$837.00M*$5.53B*(m)(m)$5.48B$1.30B
2014-03-30Reported$6.66B(m)(m)(m)36.79%$630.00M$3.92B(m)(m)$5.18B$697.00M
2013-12-29Reported$4.14B(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2013-09-29Reported$4.85B*$3.87B$976.00M*(m)(m)$809.00M*$5.95B*(m)(m)$5.31B$685.00M
2013-06-30Reported$6.01B*$5.02B$990.00M*(m)(m)$771.00M*$5.05B*(m)(m)$5.38B$960.00M
2013-03-31Reported$5.52B(m)(m)(m)31.52%$586.00M$2.28B(m)(m)$5.22B$764.00M
2012-12-30Reported$4.38B(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2012-09-30Reported$4.83B*$3.83B$1.00B*(m)(m)$682.00M*$4.98B*(m)(m)$5.23B$966.00M
2012-07-01Reported$3.51B*$2.66B$852.00M*(m)(m)$598.00M*$4.25B*(m)(m)$4.96B$627.00M
2012-04-01Reported$5.9B(m)(m)(m)(m)$502.00M$2.79B(m)(m)$5.01B$1.14B
2012-01-01Reported$1.7B(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2011-10-02Reported$5.43B*$4.65B$783.00M*(m)(m)$711.00M*$4.62B*(m)(m)$5.24B$909.00M
2011-07-03Reported$4.32B*$3.54B$777.00M*(m)(m)$618.00M*$3.91B*(m)(m)$5.21B$646.00M
2011-04-03Reported$5.48B(m)(m)(m)(m)$436.00M$2.32B(m)(m)$5.06B$1.03B
2011-01-02Reported$3.27B(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2010-10-03Reported$5.09B*$4.36B$725.00M*(m)(m)$528.00M*$5.03B*(m)(m)$4.71B$802.00M
2010-07-04Reported$5.09B*$4.38B$711.00M*(m)(m)$500.00M*$3.84B*(m)(m)$4.76B$771.00M
2010-04-04Reported(m)(m)$734.00M(m)(m)$397.00M$3.69B(m)(m)$4.78B$1.75B
2009-03-29Reported(m)(m)$676.00M(m)(m)$435.00M$2.83B(m)(m)$4.61B$1.14B

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-28Reported(m)(m)$7.50B$94.19B(m)$4.83B$24.53B$30.26B$109.00M$23.68B$5.78B
2024-12-29Reported(m)(m)$7.34B$88.82B(m)$4.42B$24.27B$27.47B$1.84B$22.87B$2.62B
2023-12-31Reported(m)(m)$7.49B$85.16B(m)$4.54B$22.79B$26.55B$483.00M$21.51B$1.74B
2023-01-01Reported(m)(m)$6.97B$79.99B(m)$4.01B$21.19B$24.60B$0.00$20.25B$2.99B
2022-01-02Reported(m)(m)$7.39B$78.74B(m)$3.65B$23.41B$23.40B$0.00$20.12B$1.38B
2021-01-03Reported(m)(m)$7.23B$82.58B(m)$3.35B$23.54B$28.43B(m)$22.08B$1.78B
2019-12-29Reported(m)(m)$7.01B$82.06B(m)$3.50B$23.42B$27.56B(m)$22.18B$2.21B
2018-12-30Reported(m)(m)$6.93B$81.58B(m)$3.67B$22.20B$27.09B(m)$22.54B$2.70B
2017-12-31Reported(m)(m)$5.64B$76.45B(m)$3.28B$21.06B$25.44B(m)$21.52B$16.37B
2017-01-01Reported(m)(m)$3.75B$71.89B(m)$3.23B$18.77B(m)(m)$20.07B$3.26B
2016-01-03Reported(m)(m)$3.75B(m)(m)$3.46B$19.57B(m)(m)$21.20B$3.79B
2014-12-28Reported$25.49B(m)(m)(m)(m)$3.71B$18.71B(m)(m)$21.95B$4.24B
2013-12-29Reported$20.52B(m)(m)(m)(m)$3.60B$17.41B(m)(m)$21.83B$1.64B
2012-12-30Reported$18.62B(m)(m)(m)(m)$2.93B$15.40B(m)(m)$20.87B$3.26B
2012-01-01Reported$16.92B(m)(m)(m)(m)$2.89B$14.30B(m)(m)$20.97B$2.69B
2011-01-02Reported$20.64B(m)(m)(m)(m)$2.38B$16.39B(m)(m)$19.42B$3.61B
2010-01-03Reported$19.36B(m)(m)(m)(m)$2.37B$16.57B(m)(m)$19.80B$3.49B
2008-12-28Reported(m)(m)$2.83B(m)(m)$3.07B$14.97B(m)(m)$21.49B$3.98B
2007-12-30Reported(m)(m)$2.78B(m)(m)$2.94B$15.02B(m)(m)$20.45B$2.71B

Similar stocks

Stock NameCountryMarket CapPE Ratio
AbbVie Inc. (ABBV)United States$468.180B70.37
Merck & Co., Inc. (MRK)United States$365.215B99.96
ELI LILLY & Co (LLY)United States$1,113.804B42.28
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
PFIZER INC (PFE)United States$162.042B31.94
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38